Rituximab Rituximab is a monoclonal anti-CD20 antibody used for the treatment of hematooncological malignancies originating from CD20-expressing B-cells, such as chronic lymphocytic leukemia (CLL), diffuse large B cell lymphoma, follicular lymphoma, or for selected autoimmune diseases (rheumatoid arthritis or systemic lupus erythematosus) (137139)
[1] [3] Hypersensitivity to cobalt or any cobalamin is a contraindication to B12 injections
The primary concern is peptide denaturation, where elevated temperatures disrupt the hydrogen bonds and hydrophobic interactions that maintain the peptide's active three-dimensional structure
A review and meta-analysis of multiple studies on L-carnitine supplementation highlights its effects on various health outcomes such as weight loss, insulin resistance, and infertility, emphasizing the importance of systematic reviews in providing comprehensive insights from randomized clinical trials
GHK-Cu addresses the secondary tissue concerns that often accompany rapid weight loss: skin laxity, hair thinning, and inflammation